Electroacupuncture Neural Stimulation Mitigates Bladder Dysfunction and Mechanical Allodynia in Cyclophosphamide Induced Cystitis through Downregulation of the BDNF-TrkB Signaling Pathway.

Researchers have discovered that electroacupuncture may effectively treat bladder pain syndrome and interstitial cystitis, conditions that cause chronic bladder pain and frequent urination. These painful conditions involve central sensitization, where the nervous system becomes overly sensitive to pain signals. In this study, scientists used rats with chemically-induced bladder inflammation to test whether electroacupuncture could reduce pain and improve bladder function. The treatment involved applying electrical stimulation to specific acupuncture points near the sacral nerves in the lower back region. The results were promising: electroacupuncture significantly reduced pain sensitivity, improved urinary function, and decreased inflammation in the nervous system. The researchers found that the treatment worked by influencing a specific biological pathway called BDNF-TrkB signaling in the spinal cord, which plays a key role in pain processing. The treatment also reduced the activation of microglial cells, immune cells in the nervous system that contribute to chronic pain when overactive. Advanced genetic analysis revealed that electroacupuncture may work by calming overexcited nerve signals and affecting pathways related to cellular health and longevity. For patients suffering from bladder pain syndrome or interstitial cystitis, this research suggests that electroacupuncture could offer a non-pharmaceutical option for managing chronic pain and improving quality of life. While this study was conducted in animals, the findings provide important evidence for how electroacupuncture might help humans with these challenging conditions. If considering this treatment approach, patients should seek care from a qualified, licensed acupuncturist experienced in treating pelvic pain conditions.

This study investigated electroacupuncture (EA) neural stimulation for cyclophosphamide-induced cystitis in rats, targeting sacral nerves (S2-S4) at the hypochondriac point. Methodology included mechanical pain threshold testing, urodynamic studies, Western blotting, immunofluorescence, and transcriptomic analysis. Key findings demonstrated that EA significantly reduced mechanical allodynia, enhanced urinary function, and suppressed microglial activation in the spinal dorsal horn. The primary mechanism involved downregulation of BDNF-TrkB signaling pathway, a critical mediator of central sensitization. Transcriptome sequencing revealed EA's effects on inhibiting excitatory neural transmission and modulating longevity-related pathways. Clinical implications suggest EA therapy targeting sacral nerve regions may effectively address central sensitization in bladder pain syndrome/interstitial cystitis through neuroinflammatory modulation. The study provides mechanistic evidence supporting EA as a therapeutic intervention for BPS/IC-related pain hypersensitivity, though sample sizes were not specified in the abstract. These findings support clinical application of EA for chronic pelvic pain conditions involving central sensitization mechanisms.